Flu vaccine is safe for hospitalized patients

January 08, 2019

Hospitalized patients who received the flu vaccine had no increased risk of outpatient visits or hospital readmission within seven days of discharge, according to a Kaiser Permanente study published today in Mayo Clinic Proceedings.

The study also showed that vaccinating hospital patients did not increase the risk of fever or rates of laboratory evaluations for infection. It also showed that the vast majority of patients who were not vaccinated during their hospital stay remained unvaccinated for the full flu season.

"We know rates of inpatient flu vaccination are low, often due to physician concerns that the vaccine could complicate healing or delay hospital discharge," said Sara Y. Tartof, PhD, MPH, study lead author, Kaiser Permanente Southern California Department of Research & Evaluation. "Our findings demonstrate that not vaccinating patients during a hospitalization may be a missed opportunity. Right now, only 28 percent of patients not already vaccinated prior to hospitalization are being vaccinated before they leave the hospital."

This study builds upon previous research that showed surgical patients who received the flu vaccine during their hospital stay did not have increased risks of complications or delay in discharge compared to surgical patients who were not vaccinated during their stay.

The flu is a highly contagious respiratory infection that can cause serious complications, hospitalizations and, in some cases, even death. Some people -- such as older adults, young children and people with certain health conditions -- are at high risk for serious complications if they get the flu. In addition to recommending annual flu vaccination for people ages 6 months and older, the Centers for Disease Control and Prevention recommends hospitalized patients who are eligible receive the flu vaccine before discharge.

This retrospective cohort study looked at the electronic health records of more than 250,000 patients ages 6 months and older who were hospitalized in a Kaiser Permanente hospital in Southern California during any of three flu seasons from 2011 to 2014 with admission and discharge dates between September 1 and March 31 of the following calendar year.

Researchers found:"This research backs up what many physicians have known intuitively for some time: Giving patients the flu vaccine while they are hospitalized is convenient and, most important, safe," said Bruno J. Lewin, MD, a family practice physician at the Kaiser Permanente Los Angeles Medical Center. "Unless there are contraindications, physicians should have no hesitation to vaccinate patients with the flu vaccine while they are hospitalized."
-end-
The study was funded through the Vaccine Safety Datalink by the Centers for Disease Control and Prevention.

Other authors of the study include senior author Steven J. Jacobsen, MD, PhD; and Lei Qian, PhD; In-Lu Amy Liu, MS; Hung Fu Tseng, PhD; Lina S. Sy, MPH; and Rulin C. Hechter, MD, PhD, of the Kaiser Permanente Southern California Department of Research & Evaluation; and Bruno J. Lewin, MD, with the Southern California Permanente Medical Group.

Vaccine research is an active area of study at Kaiser Permanente.

About the Kaiser Permanente Southern California Department of Research & Evaluation

The Department of Research & Evaluation conducts high-quality, innovative research into disease etiology, prevention, treatment and care delivery. Investigators conduct epidemiologic research, health services research, biostatistics research, and behavioral research as well as clinical trials. Major areas of study include chronic disease, infectious disease, cancer, drug safety and effectiveness, and maternal and child health. Headquartered in Pasadena, California, the department focuses on translating research to practice quickly to benefit the health and lives of Kaiser Permanente Southern California members and the general public. Visit kp.org/research.

About Kaiser Permanente

Kaiser Permanente is committed to helping shape the future of health care. We are recognized as one of America's leading health care providers and not-for-profit health plans. Founded in 1945, Kaiser Permanente has a mission to provide high-quality, affordable health care services and to improve the health of our members and the communities we serve. We currently serve more than 12.2 million members in eight states and the District of Columbia. Care for members and patients is focused on their total health and guided by their personal Permanente Medical Group physicians, specialists and team of caregivers. Our expert and caring medical teams are empowered and supported by industry-leading technology advances and tools for health promotion, disease prevention, state-of-the-art care delivery and world-class chronic disease management. Kaiser Permanente is dedicated to care innovations, clinical research, health education and the support of community health. For more information, go to kp.org/share.

Kaiser Permanente

Related Flu Vaccine Articles from Brightsurf:

A step toward a universal flu vaccine
Researchers at MIT and the Ragon Institute of MIT, MGH, and Harvard are now working on strategies for designing a universal flu vaccine that could work against any flu strain.

Study provides insight on how to build a better flu vaccine
Repeated exposure to influenza viruses may undermine the effectiveness of the annual flu vaccine.

Flu vaccine could protect against serious heart and stroke complications
The rate of seasonal flu vaccinations among people over age 50 and nursing home residents is extremely low, and those who do get the flu vaccine can significantly lower their risk of heart attack, TIA (transient ischemic attack), death and cardiac arrest.

Study suggests universal flu vaccine may be more challenging than expected
Some common strains of influenza have the potential to mutate to evade broad-acting antibodies that could be elicited by a universal flu vaccine, according to a study led by scientists at Scripps Research.

'Dirty' mice could help make a more effective flu vaccine
Studying mice that have been exposed to other illnesses could help make vaccine development processes more reflective of real-world conditions and lead to better vaccines, according to a new study.

Lifetime flu vaccine?
Another year, another flu vaccine because so far scientists haven't managed to make a vaccine that protects against all strains of flu.

Flu vaccine is safe for hospitalized patients
Hospitalized patients who received the flu vaccine had no increased risk of outpatient visits or hospital readmission within seven days of discharge, according to a Kaiser Permanente study published today in Mayo Clinic Proceedings.

Close flu vaccine supply gaps to ease flu seasons, make pandemics less deadly
Gaps in the logic of how we restock flu vaccines may be costing hundreds of lives, or more.

Near-infrared spectroscopy could improve flu vaccine manufacturing
Recent research outlines how near-infrared spectroscopy could be used to make cell-culture-based flu vaccine manufacturing faster and more efficient.

An effective adjuvanted intradermal flu vaccine for humans
An intradermal vaccine equipped with an immune response-boosting adjuvant protected ferrets and humans against one of the more lethal strains of pandemic flu, researchers report.

Read More: Flu Vaccine News and Flu Vaccine Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.